DT Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5
| Closed | -$690 | – | 538 |
|
|
2024
Q1 | $690 | Hold |
5
| – | – | ﹤0.01% | 457 |
|
|
2023
Q4 | $711 | Hold |
5
| – | – | ﹤0.01% | 456 |
|
|
2023
Q3 | $563 | Hold |
5
| – | – | ﹤0.01% | 453 |
|
|
2023
Q2 | $518 | Hold |
5
| – | – | ﹤0.01% | 459 |
|
|
2023
Q1 | $521 | Hold |
5
| – | – | ﹤0.01% | 460 |
|
|
2022
Q4 | $597 | Hold |
5
| – | – | ﹤0.01% | 480 |
|
|
2022
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 450 |
|